Access to Revolutionary Cancer Gene Therapies Remains Limited

This report highlights that although targeted gene therapies have proven highly effective in stopping cancers, many patients do not receive these treatments. The abundance of options, high costs, and slow adoption processes are significant barriers to wider access.

Originally published by nyt